Full-Time
Posted on 4/18/2026
Offers online doctor visits and e-prescriptions
No salary listed
Munich, Germany
In Person
TeleClinic is a telehealth platform in Germany that connects patients with licensed doctors for remote medical consultations. Through its app, patients can have on-demand video visits and receive electronic prescriptions that can be sent to a pharmacy for delivery or pickup. The service is available 24/7 and is accessible to anyone with statutory health insurance in Germany. TeleClinic aims to provide easy, around-the-clock access to medical advice and treatment, reducing the need for in-person visits and wait times while integrating digital prescriptions into the German healthcare system. What sets TeleClinic apart is its focus on the German market with a strong emphasis on accessibility, real-time care, and seamless electronic prescriptions, addressing busy patients’ needs and working within the public insurance framework to expand digital health access.
Company Size
51-200
Company Stage
Acquired
Total Funding
$62.7M
Headquarters
Munich, Germany
Founded
2015
Help us improve and share your feedback! Did you find this helpful?
Urban Sports Club Membership Discount
Access to eLearning platforms such as LinkedIn Learning or Reforge
Mobility discounts: Jobrad & Finn.auto
Company pension scheme with attractive employer contributions
30 days vacation per year
Shopping discounts through Corporate Benefits
Opportunity to participate in the employee participation program (stock options)
Up to 1.000€ in personal development budget & 2 days off for personal development
Training Budget: €1.500 per year, plus 5 days of educational leave
According to a Bloomberg report, the Swiss online pharmacy is currently weighing several options. A sale is also not ruled out. Swiss online pharmacy Zur Rose is said to be weighing up various strategic options, including possibly a sale, according to a Bloomberg report. According to the report, the company has held talks with potential buyers in recent months, including U.S. buyout firms KKR & Co and Hellmann & Friedmann, Bloomberg writes, citing people familiar with the matter